AUS
NZ
UK
CA
USA
IND
Highlights:
International Flavors & Fragrances Inc. (IFF) is scheduled to announce its fiscal Q3 earnings on November 4, with analysts projecting a profit of $1.05 per share, marking an 18% increase from the previous year.
Over the past year, IFF's stock has surged by 54.5%, significantly outperforming the S&P 500 Index and the Materials Select Sector SPDR Fund.
Despite a positive Q2 report, concerns about declining sales in key segments and rising costs have led to a cautious consensus rating of "Moderate Buy" among analysts.
International Flavors & Fragrances Inc. (NYSE:IFF) a prominent player in the specialty chemicals sector with a market capitalization of approximately $27 billion, is set to release its fiscal Q3 earnings results on November 4. The company, based in New York, specializes in high-value ingredients and solutions tailored for the food, beverage, personal care, and health and wellness industries. Analysts anticipate that IFF will report earnings of $1.05 per share for the quarter, an increase of nearly 18% from $0.89 per share in the same period last year. Historically, IFF has managed to exceed Wall Street's bottom-line estimates in three of the past four quarters, with a notable 14.9% beat on consensus EPS estimates in the most recent quarter.
For fiscal 2024, analysts forecast an EPS of $4.23 for IFF, reflecting a 26.7% increase compared to the $3.34 reported in fiscal 2023. The stock has shown robust performance, appreciating 54.5% over the past 52 weeks, significantly outpacing the broader S&P 500 Index, which rose by 33.6%, and the Materials Select Sector SPDR Fund, which recorded a 22.8% increase during the same period.
However, despite reporting better-than-expected adjusted EPS of $1.16 and revenue of $2.9 billion on August 6, the stock experienced a 2.4% decline the following day due to concerns about declining sales in critical segments, particularly the Nourish segment, which experienced a 5.5% year-over-year drop. Increased research and development costs, alongside rising administrative expenses, have also weighed on profitability. Additionally, concerns regarding reduced cash generation and elevated debt levels have raised questions about the company’s long-term financial health.
Analysts maintain a cautious yet optimistic consensus rating on IFF, with a "Moderate Buy" classification. Out of 19 analysts covering the stock, the breakdown includes 10 "Strong Buys," eight "Holds," and one "Strong Sell." The overall consensus reflects a more bullish outlook compared to three months ago, with the average analyst price projection suggesting a modest potential upside from current levels.
